LUCIRA HEALTH INC (LHDX)

US54948U1051 - Common Stock

0.4523  -0.11 (-19.23%)

After market: 0.405 -0.05 (-10.46%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023
Revenue
YoY % growth
270K93.055M
34,364.81%		226.7M
143.62%
EBITDA
YoY % growth
-13.58M
-41.90%		-31.65M
-133.06%		-53.527M
-69.12%		-149.532M
-179.36%
EBIT
YoY % growth
-13.86M
-41.14%		-31.93M
-130.38%		-57.198M
-79.14%		-155.285M
-171.49%
Operating Margin
N/A-11,825.93%-61.47%-68.50%
EPS
YoY % growth
N/AN/A-1.38-0.23
83.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22
EPS
Q2Q % growth		-0.41
-4,180.00%
Revenue
Q2Q % growth		35.353M
-42.16%
EBITDA
Q2Q % growth		-18.105M
EBIT
Q2Q % growth		-18.737M
-526.67%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 -3.15
-570.21%		-0.39-2.76-705.63%
Q2 2022
Q2Q % growth		 -0.45
-18.42%		-0.35-0.10-29.76%
Q1 2022
Q2Q % growth		 0.40
174.07%		-0.080.48590.20%
Q4 2021
Q2Q % growth		 0.01 -0.560.57101.79%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 34.39M
129.63%		33.446M944K2.82%
Q2 2022
Q2Q % growth		 26.146M
110.19%		30.651M-4.505M-14.70%
Q1 2022
Q2Q % growth		 90.474M
1,901.64%		87.057M3.417M3.93%
Q4 2021
Q2Q % growth		 61.124M
∞%		41.463M19.661M47.42%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -280.95% 0% 43.44%
Revenue0% -52.09% 0% -7.38%